SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Valgimigli Marco)
 

Sökning: WFRF:(Valgimigli Marco) > (2020) > Mylotte Darren > Trial Design Princi...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005826naa a2200697 4500
001oai:DiVA.org:uu-423245
003SwePub
008201021s2020 | |||||||||||000 ||eng|
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4232452 URI
0247 a https://doi.org/10.1016/j.jacc.2020.06.0852 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Capodanno, Davideu Univ Catania, Azienda Osped Univ Policlin G Rodolico San Marco, Div Cardiol, Catania, Italy.4 aut
2451 0a Trial Design Principles for Patients a High Bleeding Risk Undergoing PCI JACC Scientific Expert Panel
264 1b ELSEVIER SCIENCE INC,c 2020
338 a print2 rdacarrier
520 a Investigating the balance of risk for thrombotic and bleeding events after percutaneous coronary intervention (PCI) is especially relevant for patients at high bleeding risk (HBR). The Academic Research Consortium for HBR recently proposed a consensus definition in an effort to standardize the patient population included in HBR trials. The aim of this consensus-based document, the second initiative from the Academic Research Consortium for HBR, is to propose recommendations to guide the design of clinical trials of devices and drugs in HBR patients undergoing PCI. The authors discuss the designs of trials in HBR patients undergoing PCI and various aspects of trial design specific to HBR patients, including target populations, intervention and control groups, primary and secondary outcomes, and timing of endpoint reporting. (C) 2020 by the American College of Cardiology Foundation.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
653 a high bleeding risk
653 a percutaneous coronary intervention
653 a trial design
7001 a Morice, Marie-Claudeu Cardiovasc European Res Ctr, Massy, France.4 aut
7001 a Angiolillo, Dominick J.u Univ Florida, Coll Med, Div Cardiol, Jacksonville, FL USA.4 aut
7001 a Bhatt, Deepak L.u Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA 02115 USA.4 aut
7001 a Byrne, Robert A.u Mater Private Hosp, Cardiovasc Res Inst Dublin, Dublin, Ireland.;Royal Coll Surgeons Ireland, Sch Pharm & Biomol Sci, Dublin, Ireland.4 aut
7001 a Colleran, Roisinu Mater Private Hosp, Cardiovasc Res Inst Dublin, Dublin, Ireland.;Tech Univ Munich, Deutsches Herzzentrum Munchen, Munich, Germany.4 aut
7001 a Cuisset, Thomasu Aix Marseille Univ, CHU Timone, Dept Cardiol, Marseille, France.;Aix Marseille Univ, Fac Med, Ctr Rech Cardiovasc & Nutr, INRA,INSERM, Marseille, France.4 aut
7001 a Cutlip, Donaldu Harvard Med Sch, Beth Israel Deaconess Med Ctr, Cardiol Div, Boston, MA 02115 USA.4 aut
7001 a Eerdmans, Pedrou DEKRA Certificat, Arnhem, Netherlands.4 aut
7001 a Eikelboom, Johnu McMaster Univ, Dept Med, Hamilton, ON, Canada.4 aut
7001 a Farb, Andrewu US FDA, Silver Spring, MD USA.4 aut
7001 a Gibson, C. Michaelu Harvard Med Sch, Boston, MA 02115 USA.;Baim Inst Clin Res, Brookline, MA USA.4 aut
7001 a Gregson, Johnu London Sch Hyg & Trop Med, London, England.4 aut
7001 a Haude, Michaelu Lukaskrankenhaus, Stadt Kliniken Neuss, Neuss, Germany.4 aut
7001 a James, Stefan,d 1964-u Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Institutionen för medicinska vetenskaper4 aut0 (Swepub:uu)stjam367
7001 a Kim, Hyo-Soou Seoul Natl Univ Hosp, Cardiovasc Ctr, Seoul, South Korea.4 aut
7001 a Kimura, Takeshiu Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.4 aut
7001 a Konishi, Akihideu Pharmaceut & Med Devices Agcy, Off Med Devices 1, Tokyo, Japan.4 aut
7001 a Leon, Martin B.u Columbia Univ, Med Ctr, New York, NY USA.;Cardiovasc Res Fdn, New York, NY USA.4 aut
7001 a Magee, P. F. Adrianu US FDA, Silver Spring, MD USA.4 aut
7001 a Mitsutake, Yoshiakiu Pharmaceut & Med Devices Agcy, Off Med Devices 1, Tokyo, Japan.4 aut
7001 a Mylotte, Darrenu Univ Hosp, Galway, Ireland.;Natl Univ Ireland, Galway, Ireland.4 aut
7001 a Pocock, Stuart J.u London Sch Hyg & Trop Med, London, England.4 aut
7001 a Rao, Sunil V.u Duke Clin Res Inst, Durham, NC USA.4 aut
7001 a Spitzer, Ernestu Erasmus MC, Thoraxctr, Rotterdam, Netherlands.;Clin Trial Management & Core Labs, Cardialysis, Rotterdam, Netherlands.4 aut
7001 a Stockbridge, Normanu US FDA, Silver Spring, MD USA.4 aut
7001 a Valgimigli, Marcou Univ Bern, Dept Cardiol, Inselspital, Bern, Switzerland.4 aut
7001 a Varenne, Olivieru Hop Cochin, AP HP, Serv Cardiol, Paris, France.;Univ Paris 05, Sorbonne Paris Cite, Paris, France.4 aut
7001 a Windhovel, Uteu Cardiovasc European Res Ctr, Massy, France.4 aut
7001 a Krucoff, Mitchel W.u Duke Clin Res Inst, Durham, NC USA.;Duke Univ, Med Ctr, Durham, NC USA.4 aut
7001 a Urban, Philipu La Tour Hosp, Geneva, Switzerland.4 aut
7001 a Mehran, Roxanau Icahn Sch Med Mt Sinai, New York, NY 10029 USA.4 aut
7102 a Univ Catania, Azienda Osped Univ Policlin G Rodolico San Marco, Div Cardiol, Catania, Italy.b Cardiovasc European Res Ctr, Massy, France.4 org
7730 t Journal of the American College of Cardiologyd : ELSEVIER SCIENCE INCg 76:12, s. 1468-1483q 76:12<1468-1483x 0735-1097x 1558-3597
8564 u https://doi.org/10.1016/j.jacc.2020.06.085
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-423245
8564 8u https://doi.org/10.1016/j.jacc.2020.06.085

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy